Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I

Journal of Cell Biology

Volumn 121, Issue 3, 1993, Pages 679-687

  Jones, John I ^a   Gockerman, Amy ^a   Busby Jr , Walker H ^a   Camacho Hubner, Cecilia ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; BINDING KINETICS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FETUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SKIN FIBROBLAST;

BINDING, COMPETITIVE; CARRIER PROTEINS; CELLS, CULTURED; COLLAGEN; COMPARATIVE STUDY; DRUG SYNERGISM; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBRONECTINS; HUMAN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH-FACTOR-BINDING-PROTEIN 5; IONS; LAMININ; SKIN; SOMATOMEDINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027160032     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.121.3.679     Document Type: Article

References (45)

1. Andres, J. L., K. Stanley, S. Cheifetz, and J. Massague. 1989. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β. J. Cell Biol. 109:3137-3145.
2. Bashkin, P., S. Doctrow, M. Klagsbrun, C. M. Svahn, J. Folkman, and I. Vlodavsky. 1989. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparinlike molecules. Biochemistry. 28:1737-1743.
3. Bourner, M. J., W. H. Busby, N. R. Seigel, G. G. Krivi, R. H. McCusker, and D. R. Clemmons. 1992. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J. Cell. Biochem. 48:215-226.
4. Bradley, R. S., and A. M. C. Brown. 1990. The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix. EMBO (Eur. Mol. Biol. Organ.) J. 5:1569-1575.
5. Busby, W. H., D. G. Klapper, and D. R. Clemmons. 1988. Purification of a 31000 dalton insulin like growth factor binding protein from human amniotic fluid. J. Biol. Chem. 263:14203-14210.
6. Busby, W. H., D. K. Snyder, and D. R. Clemmons. 1988. Radioimmunoassay of a 26,000 dalton plasma insulin like growth factor binding protein: control by nutritional variables. J. Clin. Endocrinol. & Metab. 67:1225-1230.
7. Camacho-Hubner, C., W. H. Busby, R. H. McCusker, G. Wright, and D. R. Clemmons. 1992. Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem. 267:11949-11956.
8. Clemmons, D. R. 1991. Insulin-like growth factor binding proteins: roles in regulating IGF physiology. J. Dev. Physiol. 15:105-110.
9. Clemmons, D. R., R. G. Elgin, V. K. M. Han, S. J. Casella, A. J. D'Ercole, and J. J. Van Wyk. 1986. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J. Clin. Invest. 77:1548-1556.
10. Clemmons, D. R., K. M. Thrailkill, S. R. Handwerger, and W. H. Busby. 1990. Three distinct forms of insulin-like growth factor binding proteins are released by decidual cells in culture. Endocrinology. 127:643-650.
11. Elgin, R. G., W. H. Busby, and D. R. Clemmons. 1987. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA. 84:3254-3258.
12. Folkman, J., M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber, and I. Vlodavsky. 1988. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am. J. Pathol. 130:393-400.
13. Han, V. K. M., A. J. D'Ercole, and P. K. Lund. 1987. Cellular location of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science (Wash. DC). 236:193-197.
14. Han, V. K. M., D. J. Hill, A. J. Strain, A. C. Towle, J. M. Lauder, L. E. Underwood, and A. J. D'Ercole. 1987. Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus. Pediatr. Res. 22:245-249.
15. Hatakeyama, M., M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyate, M. Miyasaka, and T. Taniguchi. 1989. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNAs. Nature (Lond.). 244:551-556.
16. Hempstead, B. L., D. Martin-Zanca, D. R. Kaplan, L. F. Parada, and M. V. Chao. 1991. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature (Lond.). 350:678-683.
17. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T, Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1149-1157.
18. Hill, D. J., D. R. Clemmons, S. Wilson, V. K. M. Hall, A. J. Strain, and D. G. Milner. 1989. Immunological distribution of one form of insulin-like growth factor (IGF) binding protein and IGF peptides in human fetal tissues. J. Mol. Endocrinol. 2:31-38.
19. Hossenlopp, P., D. Seurin, B. Segovia-Quinson, S. Hardouin, and M. Binoux. 1986. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:138-143.
20. Jones, J. I., A. J. D'Ercole, C. Camacho-Hubner, and D. R. Clemmons. 1991. Phosphorylation of insulin-like growth factor binding protein in cell culture and in vivo: effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA. 88:7481-7485.
21. Kiefer, M. C., J. C. Stephans, K. Crawford, K. Okino, and P. J. Barr. 1990. Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA. 87:6985-6989.
22. Klagsbrun, M., and A. Baird. 1991. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67:229-231.
23. Knudsen, B. S., P. C. Harpel, and R. L. Nachman. 1988. Plasminogen activator is associated with the extracellular matrix of cultured bovine smooth muscle cells. J. Clin. Invest. 80:1082-1088.
24. Kobayashi, S., D. R. Clemmons, and M. A. Venkatachalam. 1991. Colocalization of insulin-like growth factor binding protein with insulin-like growth factor-I in rat kidney. Am. J. Physiol. 261:F22-F28.
25. Laemmli, U. K. 1970. Cleavage of structural protein during the assembly of the head bacteriophage T4. Nature (Lond.). 227:680-685.
26. McCusker, R. H., W. H. Busby, M. H. Dehoff, C. Camacho-Hubner, and D. R. Clemmons. 1991. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF binding proteins. Endocrinology. 129:939-949.
27. Mohan, S., J. C. Jennings, T. A. Linkhart, and D. J. Baylink. 1988. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim. Biophys. Acta. 966:44-55.
28. Moscatelli, D. 1988. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J. Cell Biol. 107:753-759.
29. Nathan, C., and M. Sporn. 1991. Cytokines in context. J. Cell Biol. 113: 981-986.
30. Palmiter, R. D., R. R. Behringer, C. J. Quaife, F. Maxwell, I. H. Maxwell, and R. L. Brinster. 1987. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell. 50:435-443.
31. Preissner, K. T., J. Grulich-Henn, H. J. Ehrlich, P. Declerck, C. Justus, D. Collen, H. Pannekoek, and G. Muller-Berghaus. 1990. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J. Biol. Chem. 265:18490-18498.
32. Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (Wash. DC). 252:1705-1707.
33. Rifkin, D. B., and D. Moscatelli. 1989. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1-6.
34. Roberts, R., J. Gallagher, E. Spooncer, T. D. Allen, F. Bloomfield, and T. M. Dexter. 1988. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature (Lond.). 332: 376-378.
35. Ruoslahti, E. 1989. Proteoglycans in cell regulation. J. Biol. Chem. 264: 13369-13372.
36. Saksela, O., D. Moscatelli, A. Sommer, and D. B. Rifkin. 1988. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic digestion. J. Cell Biol. 107:743-751.
37. Scatchard, G. 1949. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 61:660-670.
38. Schmid, C., J. Rutishauser, I. Schlapfer, E. R. Froesch, and J. Zapf. 1991. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF-I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem. Biophys. Res. Commun. 179:579-585.
39. Shimasaki, S., M. Shimonaka, H.-P. Zhang, and N. Ling. 1991. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J. Biol. Chem. 266:10646-10653.
40. Sjoberg, B., M. Eriksson, E. Osterlund, S. Pap, and K. Osterlund. 1989. Solution structure of human plasma fibronectin as a function of NaCl concentration determined by small-angle X-ray scattering. Eur. Biophys. J. 17:5-11.
41. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:573-581.
42. Vlodavsky, I., J. Folkman, R. Sullivan, R. Fridman, R. Ishai-Michaela, J. Sasse, and M. Klagsbrun. 1987. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA. 84:2292-2296.
43. Wozney, J. M., V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick, and E. A. Wang. 1988. Novel regulators of bone formation: molecular clones and activities. Science (Wash. DC). 242:1528-1534.
44. Yamaguchi, Y., D. M. Mann, and E. Ruoslahti. 1990. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (Lond.). 346:281-284.
45. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:841-848.